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ABSTRACT
Objectives: Diabetes mellitus is associated with profound alterations in the levels of plasma lipids and the lipoprotein profile. Herbs and herbal drug 
preparations find wide use in alleviating the complications of uncontrolled diabetes owing to their low cost and lesser side effects. This study was 
aimed at establishing the hypolipidemic effect of methanolic extract of sea weed Gracilaria corticata on streptozotocin (STZ)-induced diabetic rats.
Methods: STZ-induced Wistar male albino rats were administered with methanolic extract of Gracilaria corticata (MGC) at a dosage of 100 mg/kg 
BW/day per orally for 45 days. Glibenclamide (600 μg/kg BW/day) administered rats served as standard drug control. Animals were sacrificed on 
46th day, biochemical parameters associated with lipid metabolism were analyzed in blood and tissue samples, statistical significance determined.
Results: Elevated levels of total cholesterol, triglycerides, and free fatty acids were observed in the plasma and tissues of diabetic rats as compared to 
MGC and glibenclamide treated groups. The diabetic rats also had elevated levels of low-density lipoprotein (LDL-C) and very low-density lipoprotein 
(VLDL-C) and decreased levels of high-density lipoprotein (HDL-C) while the MGC and glibenclamide treated rats showed near normal levels of these 
indices.
Conclusion: This study establishes the hypolipidemic potential of MGC in STZ-induced diabetic rats.
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INTRODUCTION
Diabetes mellitus is a faction of metabolic diseases characterized by 
hyperglycemia due to defects in insulin secretion, insulin action, or both. 
The chronic hyperglycemia of diabetes is linked with long-term damage, 
dysfunction and failure of different organs, especially the eyes, kidneys, 
nerves, heart, and blood vessels [1]. The predominance of diabetes is 
quickly rising everywhere throughout the globe at a terrifying rate. 
In the course of recent years, the status of diabetes has changed from 
being viewed as a mellow issue of the elderly to one of the main causes 
of morbidity and mortality influencing the adolescent and moderately 
aged individuals [2]. Streptozotocin (STZ) is a monofunctional 
glucosamine-nitrosourea compound derived from Streptomyces 
achromogenes and is one of the most frequently used agents to induce 
diabetes in experimental animals [3]. Impairments in lipid metabolism 
associated with Type II diabetes mellitus include abnormal low-
density lipoprotein (LDL) metabolism, often coupled with an increased 
very low-density lipoprotein (VLDL) secretion and impaired VLDL 
catabolism.  Patients with diabetic mellitus are more likely to develop 
microvascular and macrovascular complications than the nondiabetic 
population [4]. Although different types of oral hypoglycemic agents 
are available along with insulin for the treatment of diabetes mellitus, 
there is growing interest in herbal plant remedies due to the side effects 
associated with these therapeutic agents [5]. Diabetes mellitus has 
also been associated with an increased risk for developing premature 
atherosclerosis due to an increase in TG and LDL, and decrease in HDL 
levels [6]. In recent times, few medicinal herbs have been recognized 
for their valuable role in the treatment of diabetes worldwide and have 
been used empirically as antidiabetic and antihyperlipidemic remedies. 
Thus, phytotherapy involves the usage of herbal medications to treat 
the diseased individuals. It has been assessed that about 25 percentage 
of all recommended medicine today include ingredients derived 
from plants [7]. The pharmaceutical potential of plants has been well 
recognized in India as well. This wide acceptance of plants as medical 
sources accounts to the belief that natural products are safe. However, 
medicinal plants should be studied thoroughly to understand their 
properties, safety, and efficiency [8]. Seaweeds are marine macroscopic 
algae which form a significant constituent of marine organisms. They 
are divided into two groups, namely, microalgae and macroalgae or 
seaweed. The history of medicinal use of seaweeds in ancient China 
dates back to a period of 5000 years [9]. Seaweeds are also used as food 
supplements traditionally. Several epidemiological reports indicate that 
seaweeds have been used as medicine since time immemorial by several 
ethnic societies for the prevention and cure of chronic diseases [10,11]. 
This study was designed to establish the hypolipidemic potential of 




STZ was purchased from Sigma-Aldrich, St. Louis, USA. All other 
chemicals used were of analytical grade, obtained from E. Merck 
Limited and HIMEDIA, Mumbai, India.
Seaweed collection
Seaweeds of Gracilaria corticata were collected during the month of 
June from sea coasts of Mandapam, Rameswaram, Tamil Nadu, India.
Authentification of G. corticata seaweed
The collected G. corticata seaweed was botanically identified by 
Dr. P. Anantharaman, Associate professor, Department of CAS Marine 
Biology, Annamalai University, Annamalainagar, Tamil Nadu, and 
voucher specimen deposited.
© 2017 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2017.v10i3.16373
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Preparation of extract
G. corticata seaweed was cleaned and the necrotic parts were removed. 
The seaweeds were washed with tap water to remove any associated 
debris and shade dried at room temperature (28±2°C) for 5-8 days 
or until brittle. After complete drying, the seaweed materials were 
ground to a fine powder using electrical blender. 50 g of powdered 
G. corticata seaweeds was extracted with 200 mL of methanol using a 
soxhlet extractor. The extract was evaporated to dryness under reduced 
pressure using a rotary vacuum evaporator, yield calculated and 
stored in a refrigerator at 4°C for future use. The methanolic extract of 
Gracilaria corticata was duly abbreviated as MGC.
Experimental animals
Healthy adult male albino Wistar rats, bred and reared in Animal 
House, School of Pharmacy, Vels University, were used for the 
experiment. Weight matched animals (120-150 g) were selected 
and housed in polypropylene cages layered with husk and kept 
in a seminatural light/dark condition (12 hrs light/12 hrs dark). 
The animals were allowed free access to water and standard pellet 
diet (Amrut Laboratory Animal Feed, Pranav Agro Industries Ltd., 
Bengaluru, India). Animal handling and experimental procedures 
were approved by the Institutional Animal Ethics Committee, Vels 
University (CPCSEA Approval No. (XV/VELS/PCOL/11/2000/
CPCSEA/IAEC/30.10.2013).
Induction of diabetes
Overnight-fasted animals were induced with diabetes by a single 
intraperitoneal injection of STZ (Dose - 40 mg/kg b.w.t.) reconstituted 
in fresh citrate buffer (0.1 M, pH 4.5). STZ injected animals were 
given 20% glucose solution for 24 hrs to prevent initial drug-
induced hypoglycemic mortality. The induced animals exhibited 
massive glycosuria (determined by Benedict’s qualitative test) 
and hyperglycemia (estimated by glucose oxidase method) within 
4 days. Diabetes in STZ rats was confirmed by measuring the fasting 
blood glucose concentration, 96 hrs after injection with STZ by tail 
vein puncture. The animals with fasting blood glucose levels above 
240 mg/dL were considered diabetic and used for subsequent 
experiments.
Experimental design
The animals were randomly divided into five groups of six animals 
each. Group I (Normal control) received only water. Group II consisted 
of normal rats treated with 100 mg/kg b.w.t of MGC. Group III were 
STZ-induced rats referred to as diabetic control. Group IV consisted 
of diabetic rats treated with 100 mg/kg b.w.t of MGC. Group V animals 
were diabetic rats treated with 600 µg/kg b.w.t of glibenclamide that 
served as standard drug control.
After 45 days, the animals were anesthetized using ketamine 
(24 mg/kg BW, intramuscular injection), and sacrificed by cervical 
dislocation. Blood was collected, tissue samples of liver, kidney and 
heart excised, processed and used for further biochemical estimations.
Biochemical estimations
Total cholesterol (TC) was estimated by the method described by Allain 
et al., 1974 [12]; Triglycerides (TG) by McGowan et al., 1983 [13]; Free 
fatty acids (FFA) by Falholt et al., 1973 [14]; phospholipids (PL) by 
Zilversmit and Davis, 1950 [15]; HDL-cholesterol by Izzo et al.1981 
[16]; VLDL- and LDL-cholesterol by Friedewald et al., 1972 [17].
Statistical analysis
Data were expressed as mean±SD for control and experimental animals. 
The data were analyzed using one-way analysis of variance on SPSS/PC, 
Ver. 10 and the group means were compared by Duncan’s multiple 
range test.
RESULTS AND DISCUSSION
Type II diabetes mellitus, the most prevalent form is characterized by 
a combination of defective insulin secretion and insulin resistance [1]. 
Insulin resistance usually paves way for the onset of type II diabetes 
which is accompanied by cardiovascular risk factors such as 
dyslipidemia, hypertension followed by heart failures. This study 
analyzed the hypolipidemic effect of methanolic G. corticata extract in 
STZ-induced type II diabetic rats.
Levels of TC, TG, FFA, and phospholipids in the plasma, liver, kidney, 
and heart of diabetic rats are represented in Tables 1-4, respectively. 
The diabetic rats showed a significant increase in the levels of TC, TG, 
phospholipids and FFA while treatment with MGC decreased these 
indices significantly (p<0.05) comparable to the effects of standard 
drug glibenclamide.
Deficiency or insufficiency of insulin renders DM patients susceptible 
to lipid profile abnormalities mainly because of the derangements in 
the regulation of lipid metabolism, thereby making them more prone 
to hypercholesterolemia and hypertriglyceridemia [18]. Earlier studies 
have also reported these lipid metabolic derangements in STZ-induced 
rat models [19,20].
The hyperlipidemic manifestation of diabetes mellitus is usually treated 
through administration of lipid-lowering drugs, consumption of low-fat 
diet apart from improving glycemic control and by increasing physical 
exercises [21]. The treatment of dyslipidemia with lipid-lowering 
drugs may be associated with serious adverse side effects. Hence, the 
hypolipidemic effects of dietary components are presently receiving 
considerable attention, highlighting the importance of natural products 
as therapeutics [22]. It has been established that dietary/drug therapy 
reduces the risk of cardiovascular diseases by lowering the plasma lipid 
levels [23]. Administration of MGC to diabetic rats also decreased the 
levels of cholesterol significantly (p<0.05).
Diseases in which prolonged elevated levels of VLDL, IDL, chylomicron 
remnants, or LDL occur in the blood (e.g., diabetes mellitus, lipid 
nephrosis, hypothyroidism, and other conditions of hyperlipidemia) 
are often accompanied by premature or severe atherosclerosis. There is 
also an inverse relationship between HDL concentrations and coronary 
heart disease, and some consider that the most predictive relationship 
is the LDL: HDL cholesterol ratio [24].
In this study too, the diabetic rats had elevated levels of LDL-C and 
VLDL-C, and decreased level of HDL-C, while treatment with MGC 
improved these values significantly (p<0.05) as observed in Table 5. 
The values were almost identical to that of the diabetic rats that were 
treated with glibenclamide, the reference drug. These evidences are 
suggestive of the protective action of MGC with respect to the lipid 
metabolism parameters in Type II diabetes mellitus. Thus, our findings 
show that MGC does have an antihyperlipidemic effect, which is 
evidenced by the decreased levels of TC, TG, LDL-C, VLDL-C, FFA and PL, 
and elevated level of HDL-C in the treated rats. Phytocomponents educe 
a wide range of biological activities which include hypoglycemia, 
hypolipidemia, etc., [25]. For instance, literature reveals that Swathi R 
Dhande et al. [26] have established the antihyperlipidemic activity of 
methanolic extract of Bambusa bambos and ethanolic extract of Swertia 
chirata and the results indicated significant decreases in serum TC, TG, 
LDL-C and VLDL-C levels, and increased serum HDL-C level. In another 
study, Cinnamomum iners leaves when administrated to diabetic rats for 
12 days also increased HDL level and decreased the TC, TG, LDL, and 
VLDL levels [27].
Saponins are known to reduce serum cholesterol levels by causing 
resin-like action, thereby reducing the enterohepatic circulation of 
bile acids [28], thus increasing the conversion of cholesterol to bile 
acids resulting in low cholesterol levels [29,30]. Seaweeds are known 
to contain several inorganic and organic bioactive compounds such 
as polyphenols and tocopherols which prove to be advantageous 
to human health and are regarded as a potential source for the 
development of novel pharmaceutical agents [31]. They are also great 
sources of a wide variety of secondary metabolites categorized by a 
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Table 1: Effect of MGC on total cholesterol in plasma and tissues of STZ diabetic rats
Groups Plasma (mg/dl) Liver (mg/g tissue) Kidney (mg/g tissue) Heart (mg/g tissue)
Control 80.17±3.92a 3.62±0.31a 4.75±0.29a 2.10±0.19a
Control+MGC (100 mg/kg BW) 75.56±3.25a 3.41±0.25a 4.14±0.46a 2.24±0.10a
Diabetic control 158.04±10.73b 5.94±0.53b 8.53±0.34b 4.77±0.34b
Diabetic+MGC (100 mg/kg BW) 97.49±5.34c 4.47±0.27c 6.1±0.47c 3.12±0.19c
Diabetic+glibenclamide (600 µg/kg BW) 86.32±3.60d 4.04±0.17d 5.27±0.24d 2.71±0.17d
MGC: Methanolic extract of Gracilaria corticata, STZ: Streptozotocin, DMRT: Duncan’s multiple range test. Values are given as mean±standard deviation for six rats in 
each group, values not sharing a common superscript differ significantly at p≤0.05 (DMRT)
Table 2: Effect of MGC on triglycerides in plasma and tissues of STZ diabetic rats
Groups Plasma (mg/dL) Liver (mg/g tissue) Kidney (mg/g tissue) Heart (mg/g tissue)
Control 51.64±3.72a 3.51±0.21a 4.68±0.34a 3.82±0.27a
Control+MGC (100 mg/kg BW) 49.33±2.81a 3.49±0.28a 4.39±0.30a 3.55±0.21a
Diabetic control 143.17±11.45b 7.32±0.57b 6.89±0.52b 6.21±0.42b
Diabetic+MGC (100 mg/kg BW) 70.24±5.45c 4.85±0.36c 5.33±0.39c 4.87±0.28c
Diabetic+glibenclamide (600 µg/kg BW) 61.40±4.97d 4.29±0.24d 4.85±0.41a 4.35±0.30d
MGC: Methanolic extract of Gracilaria corticata, STZ: Streptozotocin, DMRT: Duncan’s multiple range test. Values are given as mean±standard deviation for six rats in 
each group, values not sharing a common superscript differ significantly at p≤0.05 (DMRT)
Table 3: Effect of MGC on free fatty acids in plasma and tissues of STZ diabetic rats
Groups Plasma (mg/dL) Liver (mg/g tissue) Kidney (mg/g tissue) Heart (mg/g tissue)
Control 62.84±4.72a 7.32±0.42a 5.39±0.25a 6.38±0.34a
Control+MGC (100 mg/kg BW) 59.73±3.19a 7.09±0.51a 5.23±0.62a 6.31±0.57a
Diabetic control 117.37±8.34b 15.19±0.67b 9.60±0.59b 11.34±1.18b
Diabetic+MGC (100 mg/kg BW) 81.22±5.70c 9.76±0.49c 6.56±0.64c 8.10±0.56c
Diabetic+glibenclamide (600 µg/kg BW) 72.12±5.48d 8.90±0.62d 5.14±0.33a 7.18±0.45d
MGC: Methanolic extract of Gracilaria corticata, STZ: Streptozotocin, DMRT: Duncan’s multiple range test, Values are given as mean±standard deviation for six rats in 
each group, values not sharing a common superscript differ significantly at p≤0.05 (DMRT)
Table 4: Effect of MGC on phospholipids in plasma and tissues of STZ‑diabetic rats
Groups Plasma (mg/dL) Liver (mg/g tissue) Kidney (mg/g tissue) Heart (mg/g tissue)
Control 79.32±4.47a 20.64±1.43a 15.43±1.14a 11.34±0.57a
Control+MGC (100 mg/kg BW) 80.83±6.53a 20.84±1.65a 14.19±1.23a 11.03±0.52a
Diabetic control 132.64±9.13b 51.72±3.94b 33.29±2.84b 25.17±1.72b
Diabetic+MGC (100 mg/kg BW) 96.51±5.28c 31.85±2.27c 22.02±1.92c 16.33±1.20c
Diabetic+glibenclamide (600 µg/kg BW) 85.94±4.60d 26.90±0.92d 16.28±0.70a 12.28±0.90a
MGC: Methanolic extract of Gracilaria corticata, STZ: Streptozotocin, DMRT: Duncan’s multiple range test, Values are given as mean±standard deviation for six rats in 
each group, values not sharing a common superscript differ significantly at p≤0.05 (DMRT)
Table 5: Effect of MGC on lipoprotein profile in the plasma of STZ diabetic rats
Groups HDL (mg/dL) VLDL (mg/dL) LDL (mg/dL)
Control 47.53±3.24a 10.32±0.42a 22.31±0.30a
Control+MGC (100 mg/kg BW) 45.19±2.47a 9.86±0.46a 23.54±0.49a
Diabetic control 28.98±1.31b 31.43±1.31b 86.11±3.13b
Diabetic+MGC (100 mg/kg BW) 40.03±2.29c 16.48±0.69c 36.96±1.15c
Diabetic+glibenclamide (600 µg/kg BW) 42.26±3.08c 14.88±0.54c 31.98±0.53d
MGC: Methanolic extract of Gracilaria corticata, STZ: Streptozotocin, HDL: High-density lipoprotein, VLDL: Very low-density lipoprotein, LDL: Low-density lipoprotein, 
DMRT: Duncan’s multiple range test. Values are given as mean±standard deviation for six rats in each group, values not sharing a common superscript differ significantly 
at p≤0.05 (DMRT)
wide-ranging spectrum of biological activities [32]. Phytochemical 
analysis of seaweeds revealed the presence of secondary metabolites 
such as steroids, phenolic groups, saponins, tannins, flavonoids, 
carbohydrates, coumarins and xanthoproteins [33]. They synthesize 
a diverse range of unique secondary metabolites that have not 
been reported in terrestrial plants. The antioxidant potential of 
numerous edible seaweeds was found to be remarkably high [34]. 
Cardioprotective roles of red, brown, and green algae have also been 
established recently [35]. Subashini et al. [36] have earlier proved 
the antihyperglycemic effect of different extracts of G. corticata in 
STZ-induced diabetic and normal rats. The most usually observed 
lipid abnormalities in diabetes are hypercholesterolemia and 
hypertriglyceridemia [37,38] and these contribute to coronary artery 
disease [39].
Lipid abnormalities associated with atherosclerosis is the major 
cause of cardiovascular disease in diabetes. The treatment of diabetes, 
therefore, should have a favorable effect on lipid profiles in addition 
to glycemic control. Thus, seaweeds may serve as excellent alternative 
medicinal sources that aid the prevention of long-term complications 
such as atherosclerosis and heart diseases by exerting hypolipidemic 
and cardioprotective roles.
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CONCLUSION
In conclusion, the results of this study ascertain the hypolipidemic 
potential of MGC in STZ-induced diabetic rats. However, further 
investigations are required to elucidate the detailed mechanism of 
action of the extract that brings forth its antihyperlipidemic effect.
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